Search for: "Genentech, Incorporated"
Results 1 - 8 of 8
Sorted by Relevance | Sort by Date
26 Feb 5:11 am
... (which provides that Unless otherwise provided in the certificate of incorporation, each stockholder is entitled to one vote for each share of stock held by such stockholder)
and Genentechs bylaws. They also challenge the alternative ... put Roche in a much better position to obtain the shareholder approval that it needs under the Affiliation
Agreement. Genentech is probably wagering that this endorsement is something that Roche is willing to up the ante in order to receive. That may turn out to be ...
1 Apr 11:57 am
... steps in my framework promises to improve innovation markets analysis. The first step, evaluating market concentration, incorporates the realities of innovation in the
pharmaceutical industry. A firm in preclinical studies, with roughly a 1 in 4,000 chance of reaching ... that the FTC should not have challenged the innovation market for "CD4-based
therapeutics for the treatment of AIDS and HIV infection" in the Roche-Genentech merger since Roche was in preclinical studies and Genentech was in Phase ...
13 Mar 1:38 pm
... the seventh-largest U.S. pharmaceutical company in terms of market share. It remains to be seen what effect thishas on the culture of Genentech, which is known for innovative
research and one of the best places to work. See Roche Press Release. Lions, Tigers ... following four issues: (1) Scope of the regulation and which Genetically Engineered organisms
should be regulated; (2) Incorporation into APHIS regulations of the Plant Protection Act's noxious weed authority; (3) Elimination of notification ...
10 Feb, 2007 2:59 pm
... the proper test is to imagine PHOSITA working alone in his shop, with the prior art around him. Masculine, isolated, incorporeal - he is thinking and not tinkering in the
court's description - and his relationship to the prior art is oppositional ... pending. Herceptin: a protein that targets another protein, used for women whose tumors have a particular
molecular signature. Genentech holds patents to the antibody and to treatment methods. It costs $48,000 per year, which not all insurance companies ...
1 Jun, 2007 6:45 am
... an infringer. In January 2007, the Supreme Court turned to patent license agreements. In MedImmune, Inc. v. Genentech, Inc., the Court made it easier for a patent licensee to
challenge the validity of the patent being licensed. In its most recent ... May 4 letter from Chief Justice Michel (link). But what about the district court judges? What steps will the
PTO take to incorporate the proposed post-grant opposition procedure to ensure a smooth transition? Hopefully some of these questions will be ...
5 May, 2008 8:07 am
... will address the topic of licensing patents in light of the Supreme Court's decision in MedImmune v. Genentech affecting declaratory relief jurisdiction and in Quanta v. LG
Electronics addressing restrictive licensing practices. ... potential, making differentiating between the two difficult - a situation only intensified by the increasing prevalence of IP
rights that are incorporated into a standard. The panel will discuss the Federal Trade Commission's activities in this arena, including the N-
...
27 Jul 6:40 am
... stated that applicants abuse the system by filing divisional patent applications which incorporate new or revised claims to obtain multiple patents that all cover [*863]
essentially the same invention. n35 In the case of MedImmune, Inc. v. Genentech, Inc., the question of "evergreening" patents was presented as both abusing and compromising the
integrity of the patent system. n36 Evergreening allows inventors to file endless ...
27 Sep 2:30 pm
... to the conditions and requirements of this title. - (emphases added). The utility requirement prevents mere ideas from being patented. As we noted in Genentech, Inc. v. Novo
Nordisk A/S, 108 F.3d 1361, 1366 (Fed. Cir. 1997), "[p]atent protection is ... prior art. See In re Ziegler, 992 F.2d 1197, 1201 (Fed. Cir. 1993) ("The how to use prong of section 112
incorporates as a matter of law the requirement of 35 U.S.C. § 101 that the specification disclose as a matter of fact a practical utility for ...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog Search |
Technorati | Google | MSN | Yahoo!